Chronic Limb Ischemia Clinical Trial
Official title:
Evaluation of the Success of Endovascular Peripheral Revascularization for the Treatment of Chronic Limb Ischemia by Measuring OxyHb and DeoxyHb Using a New Hyperspectral Imaging Device (OxyVu).
This trial will collect tissue oxygenation data via hyperspectral imaging before and after endovascular procedures.
This will be a nonrandomized, nonblinded, prospective observational study to correlate the results obtained with the traditional measures of success of endovascular revascularization of peripheral arteries for the treatment of chronic limb ischemia; i.e., ABPI, PVR with oxyhemoglobin (OxyHb) and deoxyhemoglobin (DeoxyHb) measurements obtained with a new imaging device manufactured by HyperMed Inc (OxyVu) that uses hyperspectral technology. ;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03294902 -
Improving Radiological Outcomes in Arterial Disease - A Pilot Evaluation of the Pedra Tissue Perfusion Monitoring System
|
||
| Active, not recruiting |
NCT02908035 -
Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)
|
Phase 2 | |
| Active, not recruiting |
NCT02479620 -
Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization
|
Phase 2 | |
| Recruiting |
NCT02479555 -
Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization
|
Phase 2 | |
| Not yet recruiting |
NCT03847597 -
Histological and Imaging Assessment of the Structural Characteristics of the Femoro-popliteal Arterial Segment
|
||
| Recruiting |
NCT06416644 -
The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)
|
N/A |